Abstract B23: Inhibition of ribosomal RNA synthesis as a new therapeutic approach to treat advanced prostate cancer

Richard J Rebello; Eric P. Kusnadi; Donald Cameron; Helen B Pearson; Analie Lesmana; Jennifer R Devlin; Denis Drygin; Ashlee K Clark; Laura Porter; John Pedersen; Ross Hannan

doi:10.1158/1538-7445.Transcontrol16-B23

Abstract B23: Inhibition of ribosomal RNA synthesis as a new therapeutic approach to treat advanced prostate cancer

Richard J Rebello, Eric P. Kusnadi, Donald Cameron, Helen B Pearson, Analie Lesmana, Jennifer R Devlin, Denis Drygin, Ashlee K Clark, Laura Porter, John Pedersen, Ross Hannan

Research output: Contribution to journal › Literature review

Original language	English
Journal	Cancer Research
Volume	77
Issue number	6
DOIs	https://doi.org/10.1158/1538-7445.Transcontrol16-B23
Publication status	Published - 2017

Access to Document

10.1158/1538-7445.Transcontrol16-B23

Cite this

@article{1b18399bf11d4ff2b6894209de2906ab,

title = "Abstract B23: Inhibition of ribosomal RNA synthesis as a new therapeutic approach to treat advanced prostate cancer",

author = "Rebello, {Richard J} and Kusnadi, {Eric P.} and Donald Cameron and Pearson, {Helen B} and Analie Lesmana and Devlin, {Jennifer R} and Denis Drygin and Clark, {Ashlee K} and Laura Porter and John Pedersen and Ross Hannan",

year = "2017",

doi = "10.1158/1538-7445.Transcontrol16-B23",

language = "English",

volume = "77",

journal = "Cancer Research",

publisher = "American Association for Cancer Research",

number = "6",

}

TY - JOUR

T1 - Abstract B23: Inhibition of ribosomal RNA synthesis as a new therapeutic approach to treat advanced prostate cancer

AU - Rebello, Richard J

AU - Kusnadi, Eric P.

AU - Cameron, Donald

AU - Pearson, Helen B

AU - Lesmana, Analie

AU - Devlin, Jennifer R

AU - Drygin, Denis

AU - Clark, Ashlee K

AU - Porter, Laura

AU - Pedersen, John

AU - Hannan, Ross

PY - 2017

Y1 - 2017

U2 - 10.1158/1538-7445.Transcontrol16-B23

DO - 10.1158/1538-7445.Transcontrol16-B23

M3 - Literature review

VL - 77

JO - Cancer Research

JF - Cancer Research

IS - 6

ER -